Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,981 | 9,160 | 7,713 | 6,096 | N/A |
| Depreciation Amortization | 7,907 | 6,405 | 5,108 | 2,989 | N/A |
| Other Working Capital | -5,118 | -7,517 | 1,057 | N/A | N/A |
| Other Operating Activity | -1,930 | 597 | 0 | 3,369 | 0 |
| Operating Cash Flow | $9,840 | $8,645 | $13,878 | $12,454 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,389 | -9,175 | N/A | N/A | N/A |
| Net Acquisitions | -4,313 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 912 | -1,673 | 4,455 | -6,389 | 0 |
| Investing Cash Flow | $-16,790 | $-10,848 | $4,455 | $-6,389 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,997 | 3,517 | 458 | 11,964 | 0 |
| Financing Cash Flow | $5,997 | $3,517 | $458 | $11,964 | $N/A |
| Exchange Rate Effect | -88 | 707 | N/A | -19 | N/A |
| Beginning Cash Position | 3,950 | 1,929 | 11,924 | -11,082 | N/A |
| End Cash Position | 2,909 | 3,950 | -17,986 | 17,147 | N/A |
| Net Cash Flow | $-1,041 | $2,021 | $5,404 | $-16,962 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,840 | 8,645 | 13,878 | 12,454 | N/A |
| Free Cash Flow | 9,840 | 8,645 | 13,878 | 12,454 | 0 |